Tempus AI (NASDAQ:TEM) Shares Down 4.1% After Insider Selling

Tempus AI, Inc. (NASDAQ:TEM)’s share price fell 4.1% during mid-day trading on Monday after an insider sold shares in the company. The stock traded as low as $48.08 and last traded at $49.31. 8,476,573 shares traded hands during trading, a decline of 8% from the average session volume of 9,223,558 shares. The stock had previously closed at $51.40.

Specifically, CEO Eric P. Lefkofsky sold 85,788 shares of Tempus AI stock in a transaction on Friday, January 24th. The shares were sold at an average price of $53.39, for a total value of $4,580,221.32. Following the transaction, the chief executive officer now directly owns 5,771,787 shares of the company’s stock, valued at approximately $308,155,707.93. The trade was a 1.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 476,209 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total value of $23,734,256.56. Following the completion of the sale, the chief executive officer now directly owns 6,502,643 shares of the company’s stock, valued at approximately $324,091,727.12. This represents a 6.82 % decrease in their position. The disclosure for this sale can be found here.

Analyst Ratings Changes

Several research firms have commented on TEM. Loop Capital lowered their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Guggenheim initiated coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 target price on the stock. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Finally, Bank of America boosted their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Tempus AI Stock Performance

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm’s 50-day moving average price is $44.36 and its two-hundred day moving average price is $47.77.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. purchased a new stake in Tempus AI in the third quarter valued at approximately $30,000. FNY Investment Advisers LLC purchased a new stake in Tempus AI in the fourth quarter valued at $67,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the third quarter valued at approximately $153,000. Stifel Financial Corp acquired a new position in Tempus AI in the third quarter valued at $218,000. Finally, James J. Burns & Company LLC acquired a new position in Tempus AI in the 4th quarter valued at about $236,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.